The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Mechanisms regulating the expression, self‐maintenance, and signaling‐function of the bradykinin B2 and B1 receptors
Abstract
Bradykinin (BK) is a potent short‐lived effector belonging to a class of peptides known as kinins. It participates in inflammatory and vascular regulation and processes including angioedema, tissue permeability, vascular dilation, and smooth muscle contraction. BK exerts its biological effects through the activation of the bradykinin B2 receptor (BKB2R) which is G‐protein‐coupled and is generally constitutively expressed. Upon binding, the receptor is activated and transduces signal cascades which have become paradigms for the actions of the Gαi and Gαq G‐protein subunits. Following activation the receptor is then desensitized, endocytosed, and resensitized. The bradykinin B1 (BKB1R) is a closely related receptor. It is activated by desArg 10‐kallidin or desArg 9‐BK, metabolites of kallidin and BK, respectively. This receptor is induced following tissue injury or after treatment with bacterial endotoxins such as lipopolysacharide or cytokines such as interleukin‐1 or tumor necrosis factor‐α. In this review we will summarize the BKB2R and BKB1R mediated signal transduction pathways. We will then emphasize the relevance of key residues and domains of the intracellular regions of the BKB2R as they relate to modulating its function (signal transduction) and self‐maintenance (desensitization, endocytosis, and resensitization). We will examine the features of the BKB1R gene promoter and its mRNA as these operate in the expression and self‐maintenance of this inducible receptor. This communication will not cover areas discussed in earlier reviews pertaining to the actions of peptide analogs. For these we refer you to earlier reviews (Regoli and Barabé, 1980, Pharmacol Rev 32:1–46; Regoli et al., 1990, J Cardiovasc Pharmacol 15(Suppl 6):S30–S38; Regoli et al., 1993, Can J Physiol Pharmacol 71:556–557; Marceau, 1995, Immunopharmacology 30:1–26; Regoli et al., 1998, Eur J Pharmacol 348:1–10). J. Cell. Physiol. 193: 275–286, 2002. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Claing, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(01)00023-5 · Cited by 519
Cited by
Leeb-Lundberg, L. M. F., Marceau, F., Müller-Esterl, W., Pettibone, D. J., & Zuraw, B. L. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.1.2 · Cited by 943
Agostoni, A., Aygören-Pürsün, E., Binkley, K. E., Blanch, A., Bork, K., Bouillet, L., Bucher, C., Castaldo, A. J., Cicardi, M., Davis, A. E., et al. (2004) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2004.06.047 · Cited by 646
Medeiros, R., Passos, G. F., Vitor, C. E., Koepp, J., Mazzuco, T. L., Pianowski, L. F., Campos, M. M., & Calixto, J. B. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707270 · Cited by 167
Association of the human bradykinin B2 receptor gene with chronic renal failure
Jozwiak, L., Drop, A., Buraczynska, K., Ksiazek, P., Mierzicki, P., & Buraczynska, M. (2004) · Molecular Diagnosis · doi:10.1007/bf03260059 · Cited by 26
Molecular Dambusters: What Is Behind Hyperpermeability in Bradykinin-Mediated Angioedema?
Debreczeni, M. L., Németh, Z., Kajdácsi, E., Farkas, H., & Cervenak, L. (2021) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-021-08851-8 · Cited by 25
Metadata
- Authors
- Prado, G. N., Taylor, L., Zhou, X., Ricupero, D., Mierke, D. F., & Polgar, P.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2002-10-10
- Volume
- 193
- Issue
- 3
- Pages
- 275-286
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2167366932
- Cited by
- 177
- References
- 1
- FWCI
- 6.05
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.